Invasive Pneumococcal Disease and Long-Term Mortality Rates in Adults, Alberta, Canada

Emerg Infect Dis. 2022 Aug;28(8):1615-1623. doi: 10.3201/eid2808.212469.

Abstract

The relationship between increased short-term mortality rates after invasive pneumococcal disease (IPD) has been frequently studied. However, the relationship between IPD and long-term mortality rates is unknown. IPD patients in Alberta, Canada, had clinical data collected that were linked to administrative databases. We used Cox proportional hazards modeling, and the primary outcome was time to all-cause deaths. First IPD events were identified in 4,522 patients, who had a median follow-up of 3.2 years (interquartile range 0.8‒9.1 years). Overall all-cause mortality rates were consistently higher among cases than controls at 30 days (adjusted hazard ratio [aHR] 3.75, 95% CI 3.29-4.28), 30‒90 days (aHR 1.56, 95% CI 1.27‒1.93), and >90 days (aHR 1.43, 95% CI 1.33-1.54). IPD increases risk for short, intermediate, and long-term mortality rates regardless of age, sex, or concurrent conditions. These findings can help clinicians focus on postdischarge patient plans to limit long-term effects after acute IPD infection.

Keywords: Alberta; Canada; bacteria; invasive pneumococcal disease; long-term mortality rates; pneumococci; proportional hazards model; respiratory infections.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aftercare
  • Alberta / epidemiology
  • Humans
  • Patient Discharge
  • Pneumococcal Infections* / epidemiology
  • Pneumococcal Vaccines
  • Streptococcus pneumoniae*

Substances

  • Pneumococcal Vaccines